Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yong-Chun Song

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Nature Communications|September 6, 2012
Naphthol radical couplings determine structural features and enantiomeric excess of dalesconols in Daldinia eschscholziiWei Fang, Shen Ji, Nan Jiang, et al.
Thoracic Cancer|September 19, 2017
Late course accelerated hyperfractionation radiotherapy for locally advanced esophageal squamous cell carcinomaMao-Bin Meng, Chao Jiang, Li-Jun Tian, et al.
Cancer Science|August 30, 2019
Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancerMao-Bin Meng, Huan-Huan Wang, Nicholas G Zaorsky, et al.
Oncotarget|February 27, 2016
Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodesHuan-Huan Wang, Nicholas G Zaorsky, Mao-Bin Meng, et al.
Oncotargets and Therapy|June 25, 2014
Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastasesZhi-Yong Yuan, Mao-Bin Meng, Chun-Lei Liu, et al.
Oncotarget|April 18, 2015
Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancerMao-Bin Meng, Huan-Huan Wang, Nicholas G Zaorsky, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2023
Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineationGeng-Min Niu, Miao-Miao Gao, Xiao-Feng Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2025
Risk-adapted stereotactic body radiation therapy for the treatment of large (>3 cm) primary lung cancer with or without histologic confirmation: A propensity score matched and weighted analysisHong-Yu Zeng, Yan-Jin Li, Chao-Zhi Ji, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Nature Communications|September 6, 2012
Naphthol radical couplings determine structural features and enantiomeric excess of dalesconols in Daldinia eschscholziiWei Fang, Shen Ji, Nan Jiang, et al.
Thoracic Cancer|September 19, 2017
Late course accelerated hyperfractionation radiotherapy for locally advanced esophageal squamous cell carcinomaMao-Bin Meng, Chao Jiang, Li-Jun Tian, et al.
Cancer Science|August 30, 2019
Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancerMao-Bin Meng, Huan-Huan Wang, Nicholas G Zaorsky, et al.
Oncotarget|February 27, 2016
Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodesHuan-Huan Wang, Nicholas G Zaorsky, Mao-Bin Meng, et al.
Oncotargets and Therapy|June 25, 2014
Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastasesZhi-Yong Yuan, Mao-Bin Meng, Chun-Lei Liu, et al.
Oncotarget|April 18, 2015
Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from non-small cell lung cancerMao-Bin Meng, Huan-Huan Wang, Nicholas G Zaorsky, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 23, 2023
Dosimetric analysis of brachial plexopathy after stereotactic body radiotherapy: Significance of organ delineationGeng-Min Niu, Miao-Miao Gao, Xiao-Feng Wang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2025
Risk-adapted stereotactic body radiation therapy for the treatment of large (>3 cm) primary lung cancer with or without histologic confirmation: A propensity score matched and weighted analysisHong-Yu Zeng, Yan-Jin Li, Chao-Zhi Ji, et al.
Pageof 6